Cytosorbents
Stock Forecast, Prediction & Price Target
Cytosorbents Financial Estimates
Cytosorbents Revenue Estimates
Cytosorbents EBITDA Estimates
Cytosorbents Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $40.10M N/A | $29.36M -26.79% | $36.34M 23.80% | Avg: $46.83M Low: $44.24M High: $49.76M avg. 28.84% | Avg: $52.34M Low: $49.68M High: $55.22M avg. 11.76% | Avg: $54.57M Low: $51.80M High: $57.57M avg. 4.26% | Avg: $222.75M Low: $211.43M High: $235.00M avg. 308.16% |
Net Income
% change YoY
| $-24.55M N/A | $-32.81M -33.60% | $-28.50M 13.12% | Avg: $-9.73M Low: $-8.93M High: $-7.14M avg. 65.84% | Avg: $-8.28M Low: $-7.17M High: $-6.25M avg. 14.91% | Avg: $-6.69M Low: $-7.17M High: $-6.25M avg. 19.13% | Avg: $80.38M Low: $75.07M High: $86.13M avg. 1300.00% |
EBITDA
% change YoY
| $-20.16M N/A | $-29.07M -44.16% | $-28.81M 0.90% | Avg: $-31.60M Low: $-33.58M High: $-29.85M avg. -9.69% | Avg: $-35.32M Low: $-37.26M High: $-33.52M avg. -11.76% | Avg: $-36.82M Low: $-38.85M High: $-34.95M avg. -4.26% | Avg: $-150.31M Low: $-158.58M High: $-142.68M avg. -308.16% |
EPS
% change YoY
| -$0.57 N/A | -$0.75 -31.57% | -$0.64 14.66% | Avg: -$0.18 Low: -$0.2 High: -$0.16 avg. 71.87% | Avg: -$0.15 Low: -$0.16 High: -$0.14 avg. 16.66% | Avg: -$0.15 Low: -$0.16 High: -$0.14 avg. 0% | Avg: $1.8 Low: $1.68 High: $1.93 avg. 1300% |
Operating Expenses
% change YoY
| $51.80M N/A | $46.92M -9.41% | $53.60M 14.22% | Avg: $47.03M Low: $44.43M High: $49.98M avg. -12.24% | Avg: $52.57M Low: $49.90M High: $55.46M avg. 11.76% | Avg: $54.81M Low: $52.03M High: $57.83M avg. 4.26% | Avg: $223.73M Low: $212.37M High: $236.04M avg. 308.16% |
FAQ
What is Cytosorbents stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 349.97% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -8.93M, average is -9.73M and high is -7.14M.
What is Cytosorbents stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 88.25% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $44.24M, average is $46.83M and high is $49.76M.
What is Cytosorbents stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 347.13% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.2, average is -$0.18 and high is $-0.16.